Oct 1 |
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
|
Oct 1 |
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
|
Sep 25 |
As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech
|
Sep 25 |
Covid-19 vaccine patent legal battle heading to Court of Appeal
|
Sep 23 |
PFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
|
Sep 22 |
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
|
Sep 20 |
Pfizer/BioNTech new COVID shot endorsed by EMA advisory panel
|
Sep 20 |
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
|
Sep 19 |
BioNTech Is More Than a Covid-19 Stock. It’s Having a Great September.
|
Sep 19 |
Mpox: Three ongoing vaccine trials to watch
|